Volker Erfle

6.9k total citations
175 papers, 5.7k citations indexed

About

Volker Erfle is a scholar working on Virology, Molecular Biology and Immunology. According to data from OpenAlex, Volker Erfle has authored 175 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Virology, 70 papers in Molecular Biology and 69 papers in Immunology. Recurrent topics in Volker Erfle's work include HIV Research and Treatment (64 papers), Virus-based gene therapy research (46 papers) and T-cell and Retrovirus Studies (23 papers). Volker Erfle is often cited by papers focused on HIV Research and Treatment (64 papers), Virus-based gene therapy research (46 papers) and T-cell and Retrovirus Studies (23 papers). Volker Erfle collaborates with scholars based in Germany, United States and Switzerland. Volker Erfle's co-authors include Gerd Sutter, Jörg Schmidt, A. Kleinschmidt, Ruth Brack‐Werner, Ingo Drexler, Markus Neumann, Ellen I. Closs, P.G. Strauss, Brian Salmons and Christine Leib‐Mösch and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Volker Erfle

170 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Volker Erfle Germany 40 2.4k 2.2k 1.9k 1.3k 939 175 5.7k
Murray B. Gardner United States 38 1.8k 0.7× 2.5k 1.1× 1.8k 1.0× 1.7k 1.3× 1.4k 1.5× 135 6.2k
Tristram G. Parslow United States 43 4.8k 2.0× 1.6k 0.7× 2.4k 1.3× 980 0.7× 1.2k 1.2× 71 8.3k
Fred C. Jensen United States 32 1.7k 0.7× 1.3k 0.6× 1.5k 0.8× 996 0.8× 1.2k 1.3× 92 4.9k
Michael Hollinshead United Kingdom 48 2.6k 1.1× 2.0k 0.9× 1.7k 0.9× 2.2k 1.7× 1.3k 1.4× 84 7.3k
P J Barr United States 39 3.0k 1.3× 849 0.4× 1.3k 0.7× 1.8k 1.4× 618 0.7× 66 7.0k
Christopher T. Jones United States 35 1.9k 0.8× 740 0.3× 1.6k 0.8× 2.4k 1.8× 748 0.8× 69 7.7k
Axel Rethwilm Germany 47 1.7k 0.7× 2.2k 1.0× 614 0.3× 1.9k 1.4× 2.4k 2.6× 137 5.6k
Reinhard Kurth Germany 51 3.1k 1.3× 1.8k 0.8× 1.8k 1.0× 1.1k 0.8× 2.2k 2.4× 216 7.5k
Sisir K. Chattopadhyay United States 34 1.4k 0.6× 1.2k 0.5× 1.5k 0.8× 727 0.6× 1.4k 1.4× 86 4.2k
Jonathan P. Stoye United Kingdom 50 4.5k 1.9× 3.3k 1.5× 3.5k 1.9× 2.0k 1.5× 2.2k 2.4× 129 9.6k

Countries citing papers authored by Volker Erfle

Since Specialization
Citations

This map shows the geographic impact of Volker Erfle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Erfle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Erfle more than expected).

Fields of papers citing papers by Volker Erfle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Erfle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Erfle. The network helps show where Volker Erfle may publish in the future.

Co-authorship network of co-authors of Volker Erfle

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Erfle. A scholar is included among the top collaborators of Volker Erfle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Erfle. Volker Erfle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dembek, Claudia J., Johannes R. Bogner, Ulrike Protzer, et al.. (2010). MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays. Gene Therapy. 17(11). 1372–1383. 13 indexed citations
2.
Cosma, Antonio, Caroline Staib, Franziska Wopfner, et al.. (2007). Evaluation of Modified Vaccinia Virus Ankara as an Alternative Vaccine against Smallpox in Chronically HIV Type 1-Infected Individuals Undergoing HAART. AIDS Research and Human Retroviruses. 23(6). 782–793. 25 indexed citations
3.
Ceccherini‐Silberstein, Francesca, Horst Wolff, Michelle Vincendeau, et al.. (2005). Identification of a novel Rev-interacting cellular protein. BMC Cell Biology. 6(1). 20–20. 26 indexed citations
4.
Ceccherini‐Silberstein, Francesca, Sebastian Walcher, Horst Wolff, et al.. (2003). Analysis of nuclear targeting activities of transport signals in the human immunodeficiency virus Rev protein. Experimental Cell Research. 291(2). 484–501. 12 indexed citations
5.
Drexler, Ingo, Caroline Staib, Wolfgang Kastenmüller, et al.. (2002). Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proceedings of the National Academy of Sciences. 100(1). 217–222. 128 indexed citations
6.
Verrier, Bernard, Roger Le Grand, Yasemin Ataman‐Önal, et al.. (2002). Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08. DNA and Cell Biology. 21(9). 653–658. 37 indexed citations
7.
Vogel, Thorsten U., Helen Horton, Deborah H. Fuller, et al.. (2002). Differences Between T Cell Epitopes Recognized After Immunization and After Infection. The Journal of Immunology. 169(8). 4511–4521. 30 indexed citations
8.
Kohleisen, Birgit, Christine Hohenadl, Elena Shumay, et al.. (2001). HIV Type 1 Nef Promotes Neoplastic Transformation of Immortalized Neural Cells. AIDS Research and Human Retroviruses. 17(7). 597–602. 17 indexed citations
9.
Seifarth, Wolfgang, et al.. (2001). Cell Type-Specific Expression and Promoter Activity of Human Endogenous Retroviral Long Terminal Repeats. Virology. 279(1). 280–291. 76 indexed citations
10.
Sandberg, Johan K., Claudia Devito, Birgit Kohleisen, et al.. (2000). Human Immunodeficiency Virus Type 1 Nef Epitopes Recognized in HLA-A2 Transgenic Mice in Response to DNA and Peptide Immunization. Virology. 273(1). 112–119. 7 indexed citations
11.
Lumniczky, Katalin, Barbara D. Tzschaschel, Harald L. Guenther, et al.. (1999). Onset and Dynamics of Osteosclerosis in Mice Induced by Reilly-Finkel-Biskis (RFB) Murine Leukemia Virus. American Journal Of Pathology. 155(2). 557–570. 10 indexed citations
12.
Neumann, Markus, Mary Saltarelli, Emilia Hadziyannis, et al.. (1994). Splicing Variability in HIV Type 1 Revealed by Quantitative RNA Polymerase Chain Reaction. AIDS Research and Human Retroviruses. 10(11). 1531–1542. 46 indexed citations
13.
Perre, Philippe Van de, Philippe Lepage, Arlette Simonon, et al.. (1992). Biological Markers Associated with Prolonged Survival in African Children Maternally Infected by the Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 8(4). 435–442. 15 indexed citations
14.
Günzburg, Walter H., Brian Salmons, Bernhard Zimmermann, et al.. (1991). A Mammary-Specific Promoter Directs Expression of Growth Hormone not only to the Mammary Gland, but also to Bergman Glia Cells in Transgenic Mice. Molecular Endocrinology. 5(1). 123–133. 73 indexed citations
15.
Schmidt, Jörg, Ellen I. Closs, Erella Livne, Volker Erfle, & Michael Silbermann. (1989). Biochemical characterization of a virus-induced osteosarcoma-like osseous lesionin vitro. Calcified Tissue International. 45(4). 232–242. 6 indexed citations
16.
Schmidt, Jörg, Arne Luz, & Volker Erfle. (1988). Endogenous murine leukemia viruses: Frequency of radiation-activation and novel pathogenic effects of viral isolates. Leukemia Research. 12(5). 393–403. 22 indexed citations
17.
Hehlmann, Rüdiger, et al.. (1985). IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany. Annals of Hematology. 50(1). 13–18. 5 indexed citations
18.
Erfle, Volker, Rüdiger Hehlmann, W. Mellert, et al.. (1985). Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemopheliacs and other patients chronically substituted with blood products. Annals of Hematology. 51(4). 243–249. 3 indexed citations
19.
Erfle, Volker, et al.. (1981). Radiation-Induced Murine Leukemias and Endogenous Retroviruses: The Time Course of Viral Expression. Hämatologie und Bluttransfusion. 26. 537–540. 4 indexed citations
20.
Hehlmann, Rüdiger & Volker Erfle. (1980). Human leukemia viruses? RNA tumor viruses, human malignancies, and concepts of viral carcinogenesis. Annals of Hematology. 41(4). 247–256. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murray B. Gardner Breakdown of academic impact, for papers by Tristram G. Parslow Breakdown of academic impact, for papers by Fred C. Jensen Breakdown of academic impact, for papers by Michael Hollinshead Breakdown of academic impact, for papers by P J Barr Breakdown of academic impact, for papers by Christopher T. Jones Breakdown of academic impact, for papers by Axel Rethwilm Breakdown of academic impact, for papers by Reinhard Kurth Breakdown of academic impact, for papers by Sisir K. Chattopadhyay Breakdown of academic impact, for papers by Jonathan P. Stoye
Rankless by CCL
2026